Dr. Jeffrey Bennett, MD
Neurology (Neurology Physician)
1675 Aurora Ct
Aurora, CO 80045
Who else practices at this address →
Adams County includes primary care (2% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Stanford University School of Medicine (1993)
- Years since graduation
- 33
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 139
Licensed in Colorado since 1994, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1993Medical school: Stanford University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
CO license 33654 (first issued 1994; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Colorado Hospital Authority Aurora, CO
- Uchealth Highlands Ranch Hospital Highlands Ranch, CO
- Longs Peak Hospital Longmont, CO
Medical groups
- University Physicians Incorporated (3,215 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 139
- Services billed
- 360
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 104 | 80 |
| Exam to measure eye deviation and range of motion | 73 | 61 |
| Exam of visual field with extended testing | 64 | 57 |
| New patient office or other outpatient visit, 60-74 minutes | 34 | 34 |
| New patient office or other outpatient visit, 45-59 minutes | 26 | 26 |
| Imaging of optic nerve | 22 | 20 |
| Established patient office or other outpatient visit, 40-54 minutes | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisone Other prescribers in Aurora, CO | 37 |
| Mycophenolate Mofetil Other prescribers in Aurora, CO | 30 |
| Topiramate Other prescribers in Aurora, CO | 17 |
| Diazepam Other prescribers in Aurora, CO | 16 |
| Gabapentin Other prescribers in Aurora, CO | 15 |
| Enspryng (satralizumab-mwge) | 12 |
| Clonazepam Other prescribers in Aurora, CO | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 82 payments worth $71,288 in total to this clinician.
| Alexion Pharmaceuticals, Inc. | $41,119 |
|---|---|
| Tanabe Pharma Corporation | $16,439 |
| Amgen Inc. | $13,570 |
| Argenx US, Inc. | $74.55 |
| Tg Therapeutics, Inc. | $38.98 |
| Novartis Pharmaceuticals Corporation | $31.27 |
| UCB, Inc. | $15.00 |
| Compensation for services other than consulting (speaking, faculty) | $32,160 |
|---|---|
| Travel and Lodging | $30,447 |
| Consulting Fee | $6,125 |
| Food and Beverage | $2,541 |
| Education | $15.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Amgen Inc. Sep 23, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to Barcelona, Spain · in-kind | $12,366 |
| Tanabe Pharma Corporation Jul 4, 2025 | Travel and Lodging travel to Sendai, Japan · in-kind | $11,214 |
| Alexion Pharmaceuticals, Inc. Dec 11, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $5,360 |
| Alexion Pharmaceuticals, Inc. Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $5,360 |
| Alexion Pharmaceuticals, Inc. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $5,360 |
| Alexion Pharmaceuticals, Inc. Nov 6, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $5,360 |
| Alexion Pharmaceuticals, Inc. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $5,360 |
| Alexion Pharmaceuticals, Inc. Jul 2, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $5,360 |
| Tanabe Pharma Corporation Aug 23, 2025 | Consulting Fee | $3,780 |
| Alexion Pharmaceuticals, Inc. Oct 15, 2025 | Consulting Fee ULTOMIRIS · Rare Disease | $2,345 |
All 51 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. Dec 11, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $5,360 |
| Alexion Pharmaceuticals, Inc. Dec 5, 2025 | Travel and Lodging travel to Denver, CO | $95.00 |
| Alexion Pharmaceuticals, Inc. Dec 5, 2025 | Travel and Lodging travel to Denver, CO | $33.60 |
| Alexion Pharmaceuticals, Inc. Dec 4, 2025 | Travel and Lodging travel to Jacksonville, FL · in-kind Company’s descriptionSpeaker Expenses | $464 |
| Alexion Pharmaceuticals, Inc. Dec 4, 2025 | Travel and Lodging travel to Jacksonville, FL · in-kind Company’s descriptionSpeaker Expenses | $192 |
| Alexion Pharmaceuticals, Inc. Dec 4, 2025 | Travel and Lodging travel to Jacksonville, FL | $44.95 |
| Alexion Pharmaceuticals, Inc. Dec 4, 2025 | Travel and Lodging travel to Jacksonville, FL | $41.93 |
| Alexion Pharmaceuticals, Inc. Nov 6, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $5,360 |
| Alexion Pharmaceuticals, Inc. Oct 31, 2025 | Travel and Lodging travel to Denver, CO | $33.60 |
| Alexion Pharmaceuticals, Inc. Oct 30, 2025 | Travel and Lodging travel to Phoenix, AZ · in-kind Company’s descriptionSpeaker Expenses | $304 |
| Alexion Pharmaceuticals, Inc. Oct 30, 2025 | Travel and Lodging travel to Phoenix, AZ · in-kind Company’s descriptionSpeaker Expenses | $237 |
| Alexion Pharmaceuticals, Inc. Oct 30, 2025 | Travel and Lodging travel to Denver, CO | $50.00 |
| Alexion Pharmaceuticals, Inc. Oct 30, 2025 | Travel and Lodging travel to Phoenix, AZ | $34.95 |
| Alexion Pharmaceuticals, Inc. Oct 30, 2025 | Travel and Lodging travel to Phoenix, AZ | $23.93 |
| Alexion Pharmaceuticals, Inc. Oct 15, 2025 | Consulting Fee ULTOMIRIS · Rare Disease | $2,345 |
| Amgen Inc. Sep 26, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to Barcelona, Spain · in-kind | $116 |
| Amgen Inc. Sep 24, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to Barcelona, Spain · in-kind | $128 |
| Amgen Inc. Sep 23, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to Barcelona, Spain · in-kind | $12,366 |
| Tanabe Pharma Corporation Aug 23, 2025 | Consulting Fee | $3,780 |
| Tanabe Pharma Corporation Aug 23, 2025 | Travel and Lodging travel to Sendai, Japan | $140 |
| Alexion Pharmaceuticals, Inc. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $5,360 |
| Alexion Pharmaceuticals, Inc. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $5,360 |
| Alexion Pharmaceuticals, Inc. Aug 8, 2025 | Travel and Lodging travel to Dayton, OH · in-kind Company’s descriptionSpeaker Expenses | $287 |
| Alexion Pharmaceuticals, Inc. Aug 8, 2025 | Travel and Lodging travel to Denver, CO · in-kind Company’s descriptionSpeaker Expenses | $284 |
| Alexion Pharmaceuticals, Inc. Aug 8, 2025 | Travel and Lodging travel to Denver, CO | $56.59 |
| Alexion Pharmaceuticals, Inc. Aug 7, 2025 | Travel and Lodging travel to Columbus, OH · in-kind Company’s descriptionSpeaker Expenses | $431 |
| Alexion Pharmaceuticals, Inc. Aug 7, 2025 | Travel and Lodging travel to Columbus, OH · in-kind Company’s descriptionSpeaker Expenses | $270 |
| Alexion Pharmaceuticals, Inc. Aug 7, 2025 | Travel and Lodging travel to Denver, CO | $60.21 |
| Alexion Pharmaceuticals, Inc. Aug 7, 2025 | Travel and Lodging travel to Columbus, OH | $25.95 |
| Tanabe Pharma Corporation Jul 6, 2025 | Travel and Lodging travel to Sendai, Japan · in-kind | $101 |
| Tanabe Pharma Corporation Jul 5, 2025 | Travel and Lodging travel to Sendai, Japan · in-kind | $267 |
| Tanabe Pharma Corporation Jul 4, 2025 | Travel and Lodging travel to Sendai, Japan · in-kind | $11,214 |
| Tanabe Pharma Corporation Jul 4, 2025 | Travel and Lodging travel to Sendai, Japan · in-kind | $621 |
| Tanabe Pharma Corporation Jul 4, 2025 | Travel and Lodging travel to Sendai, Japan · in-kind | $164 |
| Tanabe Pharma Corporation Jul 4, 2025 | Travel and Lodging travel to Sendai, Japan · in-kind | $108 |
| Tanabe Pharma Corporation Jul 4, 2025 | Travel and Lodging travel to Sendai, Japan · in-kind | $21.00 |
| Alexion Pharmaceuticals, Inc. Jul 2, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $5,360 |
| Alexion Pharmaceuticals, Inc. Jun 27, 2025 | Travel and Lodging travel to Denver, CO | $33.60 |
| Alexion Pharmaceuticals, Inc. Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $5,360 |
| Alexion Pharmaceuticals, Inc. Jun 26, 2025 | Travel and Lodging travel to Seattle, WA · in-kind Company’s descriptionSpeaker Expenses | $501 |
| Alexion Pharmaceuticals, Inc. Jun 26, 2025 | Travel and Lodging travel to Seattle, WA · in-kind Company’s descriptionSpeaker Expenses | $372 |
| Alexion Pharmaceuticals, Inc. Jun 26, 2025 | Travel and Lodging travel to Seattle, WA | $110 |
| Alexion Pharmaceuticals, Inc. Jun 20, 2025 | Travel and Lodging travel to Denver, CO | $70.00 |
| Alexion Pharmaceuticals, Inc. Jun 20, 2025 | Travel and Lodging travel to Denver, CO | $33.60 |
| Alexion Pharmaceuticals, Inc. Jun 20, 2025 | Travel and Lodging travel to Mobile, AL | $15.97 |
| Alexion Pharmaceuticals, Inc. Jun 19, 2025 | Travel and Lodging travel to Mobile, AL · in-kind Company’s descriptionSpeaker Expenses | $825 |
| Alexion Pharmaceuticals, Inc. Jun 19, 2025 | Travel and Lodging travel to Mobile, AL · in-kind Company’s descriptionSpeaker Expenses | $209 |
| Alexion Pharmaceuticals, Inc. Jun 19, 2025 | Travel and Lodging travel to Mobile, AL | $24.91 |
| Alexion Pharmaceuticals, Inc. Jun 19, 2025 | Travel and Lodging travel to Mobile, AL | $17.93 |
| Alexion Pharmaceuticals, Inc. Jun 19, 2025 | Travel and Lodging travel to Mobile, AL | $16.97 |
| UCB, Inc. Mar 12, 2025 | Education Rystiggo · Neurology · in-kind | $15.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 3 companies. The companies reported $259,573 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, External Placebo Controlled, Open Label, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)
Alexion Pharmaceuticals, Inc. - A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD)
UCB SA · Active, not recruiting · NCT05063162 - Sponsored Research Project Dr Bennett and the Regents of the University of Colorado
Alexion Pharmaceuticals, Inc. - PLP1 complex Autoantibodies and Biomarkers of Disease Activity in Multiple Sclerosis
Genentech, Inc. - A Long-Term, Prospective, Observational, Registry of Patients with Anti-Aquaporin 4 Antibody-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated with Alexion Complement Component 5 (C5) Inhibitor T…
Alexion Pharmaceuticals, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.